FR2376160B1 - - Google Patents

Info

Publication number
FR2376160B1
FR2376160B1 FR7739817A FR7739817A FR2376160B1 FR 2376160 B1 FR2376160 B1 FR 2376160B1 FR 7739817 A FR7739817 A FR 7739817A FR 7739817 A FR7739817 A FR 7739817A FR 2376160 B1 FR2376160 B1 FR 2376160B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7739817A
Other versions
FR2376160A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lark SpA
Original Assignee
Lark SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lark SpA filed Critical Lark SpA
Publication of FR2376160A1 publication Critical patent/FR2376160A1/fr
Application granted granted Critical
Publication of FR2376160B1 publication Critical patent/FR2376160B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FR7739817A 1976-12-31 1977-12-30 Steroides anti-inflammatoires utilisables comme medicaments Granted FR2376160A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB54510/76A GB1593978A (en) 1976-12-31 1976-12-31 Anti-inflammatory steroids

Publications (2)

Publication Number Publication Date
FR2376160A1 FR2376160A1 (fr) 1978-07-28
FR2376160B1 true FR2376160B1 (fr) 1980-11-14

Family

ID=10471258

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7739817A Granted FR2376160A1 (fr) 1976-12-31 1977-12-30 Steroides anti-inflammatoires utilisables comme medicaments

Country Status (10)

Country Link
JP (1) JPS53144561A (fr)
BE (1) BE862507A (fr)
CH (1) CH633301A5 (fr)
DK (1) DK155673C (fr)
FI (1) FI63422C (fr)
FR (1) FR2376160A1 (fr)
GB (1) GB1593978A (fr)
NL (1) NL7714482A (fr)
NO (1) NO148491C (fr)
SE (1) SE430607B (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1440063A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids

Also Published As

Publication number Publication date
FI63422B (fi) 1983-02-28
NO774525L (no) 1978-07-03
DK581677A (da) 1978-07-01
CH633301A5 (en) 1982-11-30
GB1593978A (en) 1981-07-22
SE430607B (sv) 1983-11-28
FR2376160A1 (fr) 1978-07-28
FI773929A (fi) 1978-07-01
JPS53144561A (en) 1978-12-15
SE7714976L (sv) 1978-07-02
FI63422C (fi) 1983-06-10
BE862507A (fr) 1978-04-14
NO148491B (no) 1983-07-11
NO148491C (no) 1983-10-19
JPS6220197B2 (fr) 1987-05-06
DK155673B (da) 1989-05-01
NL7714482A (nl) 1978-07-04
DK155673C (da) 1989-09-04

Similar Documents

Publication Publication Date Title
JPS5621409Y2 (fr)
JPS5340835U (fr)
JPS555561Y2 (fr)
FR2376160B1 (fr)
JPS5296289U (fr)
CS177789B1 (fr)
JPS5359709U (fr)
JPS5394121U (fr)
JPS5327201U (fr)
JPS52120246U (fr)
JPS5310126U (fr)
DD126691A1 (fr)
AU481267A (fr)
CH593417A5 (fr)
CH597018A5 (fr)
CH597975A5 (fr)
CH599332A5 (fr)
CH601109A5 (fr)
BG23246A1 (fr)
CH604265B5 (fr)
CH605211A5 (fr)
CH606658A5 (fr)
CH609435A5 (fr)
CH609750A5 (fr)
DD124264A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse